Annual Current Liabilities
$7.29 M
+$476.00 K+6.99%
December 31, 2023
Summary
- As of February 8, 2025, VVOS annual total current liabilities is $7.29 million, with the most recent change of +$476.00 thousand (+6.99%) on December 31, 2023.
- During the last 3 years, VVOS annual current liabilities has fallen by -$552.00 thousand (-7.04%).
- VVOS annual current liabilities is now -19.85% below its all-time high of $9.09 million, reached on December 31, 2019.
Performance
VVOS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$5.13 M
-$1.52 M-22.84%
September 30, 2024
Summary
- As of February 8, 2025, VVOS quarterly total current liabilities is $5.13 million, with the most recent change of -$1.52 million (-22.84%) on September 30, 2024.
- Over the past year, VVOS quarterly current liabilities has stayed the same.
- VVOS quarterly current liabilities is now -44.97% below its all-time high of $9.31 million, reached on June 30, 2021.
Performance
VVOS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
VVOS Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.0% | 0.0% |
| 3 y3 years | -7.0% | -37.5% |
| 5 y5 years | +237.9% | -29.7% |
VVOS Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.9% | +7.0% | -39.3% | at low |
| 5 y | 5-year | -19.9% | +7.0% | -45.0% | at low |
| alltime | all time | -19.9% | +237.9% | -45.0% | at low |
Vivos Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.13 M(-22.8%) |
| Jun 2024 | - | $6.64 M(-17.7%) |
| Mar 2024 | - | $8.07 M(+10.7%) |
| Dec 2023 | $7.29 M(+7.0%) | $7.29 M(+1.7%) |
| Sep 2023 | - | $7.17 M(-15.1%) |
| Jun 2023 | - | $8.44 M(+5.8%) |
| Mar 2023 | - | $7.97 M(+17.1%) |
| Dec 2022 | $6.81 M | $6.81 M(+14.2%) |
| Sep 2022 | - | $5.96 M(-10.9%) |
| Jun 2022 | - | $6.69 M(-2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $6.85 M(-8.8%) |
| Dec 2021 | $7.51 M(-4.2%) | $7.51 M(-8.4%) |
| Sep 2021 | - | $8.20 M(-12.0%) |
| Jun 2021 | - | $9.31 M(+27.7%) |
| Mar 2021 | - | $7.30 M(-7.0%) |
| Dec 2020 | $7.84 M(-13.8%) | $7.84 M(+12.1%) |
| Sep 2020 | - | $7.00 M(+16.3%) |
| Jun 2020 | - | $6.02 M(-33.9%) |
| Dec 2019 | $9.09 M(+321.6%) | $9.09 M |
| Dec 2018 | $2.16 M | - |
FAQ
- What is Vivos Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Vivos Therapeutics?
- What is Vivos Therapeutics annual current liabilities year-on-year change?
- What is Vivos Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Vivos Therapeutics?
- What is Vivos Therapeutics quarterly current liabilities year-on-year change?
What is Vivos Therapeutics annual total current liabilities?
The current annual current liabilities of VVOS is $7.29 M
What is the all time high annual current liabilities for Vivos Therapeutics?
Vivos Therapeutics all-time high annual total current liabilities is $9.09 M
What is Vivos Therapeutics annual current liabilities year-on-year change?
Over the past year, VVOS annual total current liabilities has changed by +$476.00 K (+6.99%)
What is Vivos Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of VVOS is $5.13 M
What is the all time high quarterly current liabilities for Vivos Therapeutics?
Vivos Therapeutics all-time high quarterly total current liabilities is $9.31 M
What is Vivos Therapeutics quarterly current liabilities year-on-year change?
Over the past year, VVOS quarterly total current liabilities has changed by $0.00 (0.00%)